Free Trial

Thermo Fisher Scientific (TMO) Stock Price, News & Analysis

Thermo Fisher Scientific logo
$699.98 +0.54 (+0.08%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$695.00 -4.98 (-0.71%)
As of 11/13/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Thermo Fisher Scientific Stock (NYSE:TMO)

Advanced

Key Stats

Today's Range
$689.71
▼
$702.03
50-Day Range
$603.43
▼
$721.96
52-Week Range
$435.27
▼
$727.56
Volume
1.84 million shs
Average Volume
2.26 million shs
Market Capitalization
$259.36 billion
P/E Ratio
36.92
Dividend Yield
0.27%
Price Target
$683.64
Consensus Rating
Moderate Buy

Company Overview

Thermo Fisher Scientific develops and supplies products and services used in scientific research, clinical diagnostics, and pharmaceutical and biotechnology manufacturing. Its offerings include laboratory instruments, reagents and consumables, analytical equipment, diagnostic tests, and services that support drug development and clinical research.

The company operates through businesses focused on life sciences, analytical instruments, specialty diagnostics, and laboratory products and biopharma services. Its brands include Thermo Scientific, Applied Biosystems, Invitrogen, and Fisher Scientific.

Thermo Fisher was formed in 2006 through the merger of Thermo Electron and Fisher Scientific, companies with roots in laboratory and scientific equipment. Based in Waltham, Massachusetts, it serves customers around the world. Marc N. Casper is the company’s chairman, president, and chief executive officer.

AI Generated. May Contain Errors.

Thermo Fisher Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

TMO MarketRank™: 
3.665354330705 of 5 stars

Thermo Fisher Scientific scored higher than 73% of companies evaluated by MarketBeat, and ranked 173rd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Thermo Fisher Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.93, and is based on 2 strong buy ratings, 23 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Thermo Fisher Scientific is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Thermo Fisher Scientific has been the subject of 23 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Thermo Fisher Scientific's stock forecast and price target.
  • Earnings Growth

    Earnings for Thermo Fisher Scientific are expected to grow by 10.13% in the coming year, from $25.27 to $27.83 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Thermo Fisher Scientific is 36.92, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Thermo Fisher Scientific is 36.92, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.56.

  • Price to Earnings Growth Ratio

    Thermo Fisher Scientific has a PEG Ratio of 2.85. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Thermo Fisher Scientific has a P/B Ratio of 4.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.30% of the float of Thermo Fisher Scientific has been sold short.
  • Short Interest Ratio / Days to Cover

    Thermo Fisher Scientific has a short interest ratio ("days to cover") of 1.97, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Thermo Fisher Scientific has recently decreased by 2.11%, indicating that investor sentiment is improving.
  • Dividend Yield

    Thermo Fisher Scientific has a dividend yield of 0.27%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Thermo Fisher Scientific has been increasing its dividend for 8 years.

  • Dividend Coverage

    The dividend payout ratio of Thermo Fisher Scientific is 9.92%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Thermo Fisher Scientific will have a dividend payout ratio of 6.76% next year. This indicates that Thermo Fisher Scientific will be able to sustain or increase its dividend.

  • Read more about Thermo Fisher Scientific's dividend.
  • News Sentiment

    Thermo Fisher Scientific has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 32 news articles for Thermo Fisher Scientific this week, compared to 10 articles on an average week.
  • Search Interest

    Only 29 people have searched for TMO on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • MarketBeat Follows

    10 people have added Thermo Fisher Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Thermo Fisher Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,479,192.00 in company stock.

  • Percentage Held by Insiders

    0.33% of the stock of Thermo Fisher Scientific is held by insiders.

  • Percentage Held by Institutions

    89.23% of the stock of Thermo Fisher Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Thermo Fisher Scientific's insider trading history.
Receive TMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TMO Stock News Headlines

Graphic panels depicting AI chips, DNA, a globe, a robotic arm, and cloud computing promote the Lazard Equity Megatrends ETF, ticker THMZ.
The Next Big Thing May Not Be One Thing: Inside Lazard's Megatrends ETF (TMO)
The Lazard Equity Megatrends ETF (THMZ) actively invests in global megatrend-driven companies, holding TSM and mega-cap tech names while carrying a 0.5% expense ratio and sector and emerging-market risks.
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
AI Is Speeding Up Drug Discovery, but FDA Trial Phases Still Decide Which Biotech Stocks Win
Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built (TMO)
Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma just began a phase 2 MS trial.
See More Headlines

TMO Stock Analysis - Frequently Asked Questions

Thermo Fisher Scientific's stock was trading at $579.42 at the beginning of 2026. Since then, TMO shares have increased by 20.8% and is now trading at $699.9830.

Thermo Fisher Scientific Inc. (NYSE:TMO) released its quarterly earnings results on Wednesday, October, 21st. The medical research company reported $6.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.40 by $0.28. The firm's quarterly revenue was up 9.1% on a year-over-year basis.
Read the conference call transcript
.

Thermo Fisher Scientific's Board of Directors approved a stock repurchase program on Thursday, November 6th 2025, which authorizes the company to buy back $5 billion in outstanding shares, according to EventVestor. This means that the company could purchase up to 2.4% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its shares are undervalued.

The following companies are subsidiaries of Thermo Fisher Scientific: Henogen, Phinotex, Qiagen, Brammer Bio, HighChem, Gatan Inc, IntegenX, and more.

Thermo Fisher Scientific's top institutional investors include Sumitomo Mitsui Trust Group Inc. (0.28%), Rathbones Group PLC (0.25%), Pictet Asset Management Holding SA (0.24%) and Voya Investment Management LLC (0.21%). Insiders that own company stock include Marc N Casper, Michel Lagarde, Stephen Williamson, Gianluca Pettiti, Michael D Shafer, Frederick M Lowery, Lisa P Britt, Michael A Boxer, Joseph R Holmes and Debora L Spar.
View institutional ownership trends
.

Shares of TMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Thermo Fisher Scientific investors own include NVIDIA (NVDA), Visa (V), Salesforce (CRM), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM) and Mastercard (MA).

Company Calendar

Record date for 10/15 Dividend
9/15/2026
Ex-Dividend for 10/15 Dividend
9/15/2026
Dividend Payable
10/15/2026
Last Earnings
10/21/2026
Today
11/15/2026
UBS 2026 CEO Call Series
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:TMO
CIK
97745
Employees
125,000
Year Founded
1956

Price Target and Rating

High Price Target
$810.00
Low Price Target
$510.00
Potential Upside/Downside
-2.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.93
Research Coverage
29 Analysts

Profitability

EPS (Trailing Twelve Months)
$18.96
Trailing P/E Ratio
36.92
Forward P/E Ratio
25.15
P/E Growth
2.85
Net Income
$6.70 billion
Net Margins
14.94%
Pretax Margin
16.68%
Return on Equity
17.33%
Return on Assets
8.18%

Debt

Debt-to-Equity Ratio
0.71
Current Ratio
1.81
Quick Ratio
1.41

Sales & Book Value

Annual Sales
$44.56 billion
Price / Sales
5.82
Cash Flow
$30.42 per share
Price / Cash Flow
23.01
Book Value
$147.81 per share
Price / Book
4.74

Miscellaneous

Outstanding Shares
370,520,000
Free Float
369,293,000
Market Cap
$259.36 billion
Optionable
Optionable
Beta
0.84

Social Links

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:TMO) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners